BridgeMD
New treatment option for Exercise Timing
Official title Exercise Timing and Postprandial Glucose Responses
ClinicalTrials.gov ID: NCT07434349
What this study is testing
- What it's testing
- This interventional crossover study examines the effect of exercise timing relative to meal intake on postprandial glucose responses in healthy, physically active young adults. Participants complete five experimental conditions involving endurance exercise performed before or after breakfast or dinner, as well as a non-exercise control condition, while wearing a continuous glucose monitoring device.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Age 18 to 35 years
- Body mass index 18.5 to 24.9 kg per square meter
- Able to complete 45 minutes of continuous running at an intensity corresponding to 75 to 85 percent of maximal heart rate without stopping
- Engages in regular endurance-type physical activity
- Habitual waking times are compatible with the fixed breakfast time of 08:00
You likely can't join if
- Acute or chronic illness
- Metabolic disorders or conditions associated with altered glucose or lipid metabolism
- Use of medications known to interfere with glucose metabolism or study outcomes
- Intolerance or allergy to components of the standardized study diets
- Pregnancy or breastfeeding
- Body mass index greater than or equal to 25 kg per square meter
See the full eligibility criteria
- Age 18 to 35 years
- Body mass index 18.5 to 24.9 kg per square meter
- Able to complete 45 minutes of continuous running at an intensity corresponding to 75 to 85 percent of maximal heart rate without stopping
- Engages in regular endurance-type physical activity
- Habitual waking times are compatible with the fixed breakfast time of 08:00
- Willing and able to comply with all study procedures, including standardized meals, exercise sessions, behavioral restrictions, and continuous glucose monitoring
- For female participants: non-pregnant and using stable hormonal contraception for at least 3 months
- Acute or chronic illness
- Metabolic disorders or conditions associated with altered glucose or lipid metabolism
- Use of medications known to interfere with glucose metabolism or study outcomes
- Intolerance or allergy to components of the standardized study diets
- Pregnancy or breastfeeding
- Body mass index greater than or equal to 25 kg per square meter
- Current or past eating disorder, or any medical condition or medication that could affect appetite regulation, glucose regulation, or make vigorous endurance exercise unsafe
- Current smoking or use of nicotine-containing products
The study team makes the final eligibility decision.
Where it's taking place
- München, Bavaria, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include München, Bavaria, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.